IBM’s Twin Engines: Software Margins and a $10bn Quantum Bet Power a 7% Rally
Published on 07/07/2026 at 03:12 | Redaktion boerse-global.de
Investors are re-rating IBM as the century-old technology giant sheds its hardware heritage and reinvents itself as a high-margin software and quantum computing contender. The stock closed at €261.00 on Monday, up 3.78% on the day and 7.30% over the past week — a rally that has carried the shares to within 11% of their 52-week high and more than 17% above the 50-day moving average.
The optimism is anchored in two distinct but complementary strategies: a rapidly expanding software portfolio that is already feeding the bottom line, and a long-term bet on quantum computing backed by more than $10bn in planned investment over the next five years. Analysts at Bank of America have given the turnaround a powerful endorsement, lifting their price target from $315 to $330 and reiterating a buy rating. Analyst Wamsi Mohan expects the upcoming second-quarter earnings release on July 22 to show revenue of $18bn and adjusted earnings per share of roughly $3, and he believes management will raise its full-year guidance for both revenue and free cash flow.
At the center of the software push sits last year’s acquisition of Confluent, a data-streaming platform that is expected to contribute around $340m in revenue to IBM’s software division. That unit, which also includes Red Hat and the company’s watsonx AI platform, is being presented to the market as the engine of margin expansion through the second half of 2026. Concrete proof of the strategy’s traction came today with the announcement of a strategic partnership between IBM, Mitsubishi UFJ Financial Group (MUFG) and Red Hat to overhaul the bank’s core systems using AI. The deal demonstrates that IBM can deploy its technology stack inside one of the world’s largest and most heavily regulated financial institutions — a signal that the company’s consulting heritage is now being fused with proprietary software products.
Should investors sell immediately? Or is it worth buying IBM?
Parallel to the software story, IBM is making headlines in quantum computing. The company has committed more than $10bn to research and development over five years, with the goal of unveiling its first fault-tolerant quantum computer, code-named “Starling,” by 2029. A recent breakthrough with the Oak Ridge National Laboratory — using a quantum system to calculate molecular structures for fusion fuel — adds credibility to the effort. IBM is also partnering with the U.S. Department of Commerce on a dedicated chip fabrication facility. While quantum revenue remains years away, analysts note that the current enterprise value of roughly €237bn leaves ample room for upside if the technology matures as planned.
Yet the rally is not without counterweights. IBM carries nearly $58bn in debt, and its legacy consulting business is growing at only 4%, a pace that highlights the gap between the company’s high-margin software ambitions and its slower-moving service operations. Chief Executive Arvind Krishna has been publicly cautious about the return on investment from artificial intelligence, warning that infrastructure costs can easily erode margins — a note of realism that has, paradoxically, reinforced investor confidence in the company’s disciplined capital allocation.
Other recent moves underscore the breadth of the transformation. Late June saw the launch of “Project Lightwell,” a cybersecurity-focused AI initiative developed jointly with Deloitte. IBM is also expanding its global quantum footprint, including a collaboration with the Cleveland Clinic and the Oak Ridge lab that produced the fusion-fuel calculation. The steady drumbeat of partnerships and product milestones is beginning to reframe IBM in the market’s imagination: no longer the stodgy mainframe maker, but a pragmatic architect of the next technology cycle with a balance sheet sturdy enough to fund both quantum moonshots and steady share buybacks. The quarterly report due next week will provide the first hard numbers on whether that narrative can sustain itself.
Ad
IBM Stock: New Analysis - 7 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
